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Abstract 
Background 
Health Assessment and medical surveillance of workers exposed to combustion 
nanoparticles is challenging. The aim was to evaluate the feasibility of using exhaled 
breath condensate (EBC) from healthy volunteers for 1) assessing the lung deposited 
dose of combustion nanoparticles; 2) determining the resulting oxidative stress by 
measuring H2O2 and MDA.  
Methods 
15 healthy non smoker volunteers were exposed to three different levels of side-stream 
cigarette smoke under controlled conditions. EBC was repeatedly collected before, 
during and 1 and 2 hours post exposure. Exposure variables were measured by direct 
reading instruments and by active sampling. The different EBC samples were analyzed 
for particle number concentration (light-scattering based method) and for selected 
compounds considered oxidative stress markers.   
Results 
Subjects were exposed to an average airborne concentration up to 4.3 x 10^5 
particles/cm3 (average geometric size ~60-80 nm). Up to 10 x 10^8 particles/ml could 
be measured in the collected EBC with a broad size distribution (50th percentile ~160 
nm) but these biological concentrations were not related to the exposure level of 
cigarette smoke particles. While H2O2 and MDA concentrations in EBC increased 
during exposure, only H2O2 showed a transient normalization 1 hour after exposure 
and increased afterward. In contrast, MDA levels  stayed elevated during the 2 hours 
post-exposure.  
Conclusions  
The use of diffusion light scattering for particle counting proved to be sufficiently 
sensible to detect objects in EBC but lacked the specificity for carbonaceous tobacco 
smoke particles. Our results suggest two phases of oxidation markers in EBC: first, the 
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initial deposition of particles and gases in the lung lining liquid, and later the start of 
oxidative stress with associated cell membrane damage. Future studies should extend 
the follow-up time and should remove gases or particles from the air to allow 
differentiating between the different sources of H2O2 and MDA.  
 
 
Keywords 
EBC, cigarette smoke, H2O2, MDA, acrolein, nanoparticle tracking analysis 
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Introduction 
Based on epidemiological studies, the fine and ultrafine fraction of ambient particles 
are of particular concern as they are associated to adverse health effects such as 
cancer, cardiovascular and pulmonary diseases (1). In the case of engineered 
nanomaterial, their increasing use leads to concern regarding their toxicity. Indeed, in 
vivo2 and in vitro3 studies suggest that such materials may be hazardous to living 
organisms. The potential health effects of manufactured nanomaterials are thus 
currently being investigated in large research projects (4). However, results from human 
studies are still scarce and need to be created (5). Among the different mechanisms 
proposed to explain these adverse effects, is the production of reactive oxygen species 
(ROS) which contribute to oxidative stress (6). This mechanism has been proposed as 
an unifying concept (7) applicable to ambient as well as for engineered nanoparticles. 
The lungs are the principal entry portal for particles and after they deposit, a rapid 
build-up of oxidative stress in the thin liquid layer of the alveolar region has been 
suggested, leading to epithelial cell damage and the release of pro-inflammatory 
mediators (8). Oxidative stress induces and is induced by airway inflammation (9) and 
this perpetuation increases the oxidative stress further, forming a vicious cycle (10). 
Both, oxidative stress and sustained inflammation can thus contribute to the onset of 
particle related pathophysiological effects including cardiovascular effects 11-15. 
Most of the human studies regarding the determination of the dose-response due to 
inhalation of particles may use radiolabeled particles (16) and collect the lung fluid by 
invasive techniques (e.g. bronchoalveolar lavage fluids or sputum induction) (9), all of 
which are not totally harmless to the volunteers. In addition, the measurement of 
inflammatory markers in urine or plasma after particle exposure reflects a systemic 
rather than an organ specific inflammation. Exhaled breath condensate (EBC), 
consisting in condensing the exhaled air of living beings (17), is an emerging and non 
invasive technique allowing to study lung processes. EBC sampling is easy to be 
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performed and may give valuable information about inflammatory events in the 
respiratory tract (18-20). As EBC is a highly diluted aqueous media, no matrix effect are 
reported (21, 22) but challenging concerning analytical techniques which must be highly 
sensitive. From a toxicological and occupational risk assessment perspective (23), EBC 
could be an ideal biological matrix as it could simultaneously provide information about 
the deposited dose and on the subsequent biological effects such as inflammation. 
EBC is thus proposed as a good methodology to study pulmonary biomarkers of 
exposure and effects in occupational situations (24, 25).   
Whereas the measurement of different metals in EBC of workers exposed to 
pneumotoxic metal particles has been reported several time (21, 26, 27), very few studies 
have tried to determine the dose of particulate matter deposited in the lungs by using 
EBC. Falgayrac (28) presented preliminary results indicating that the combination of 
EBC collection and Raman spectroscopy could be useful to identify micrometric size 
mica particles in lungs of exposed workers. By using nuclear microprobe techniques, 
Pinheiro (29) demonstrated the feasibility of detecting and characterizing the elemental 
composition of particles in dried EBC samples collected from workers in a smelting 
factory. 
As oxidative stress is an important mechanism explaining the biological effect of 
deposited particles in lungs, corresponding relevant biomarkers of effect in EBC have 
to be considered. Superoxide plays a central role in the generation of oxidative stress, 
as it is one of the species which can be catalytically induced by particles. In biological 
tissues, this radical is rapidly transformed to the stable hydrogenperoxide (H2O2) or 
may oxidise cells constituents like lipids. Increased levels of H2O2 and 
malondialdehyde (MDA, considered as a marker of lipoperoxidation) have been 
reported in EBC of healthy volunteers after wood-smoke exposure (30) or for asthmatic 
children exposed to ambient particle (31, 32). Compared to controls, patients with asthma  
(33) and asbestosis or silicosis (34) presented also higher levels in EBC for such 
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compounds. These two molecules are thus often considered as good oxidative stress 
biomarkers in EBC (18). 
The aim of this study was to evaluate the feasibility of using EBC for 1) assessing the 
deposited dose of combustion-based nanoparticles (NP) in the lungs of healthy 
volunteers and 2) determining the resulting oxidative stress level by measuring H2O2 
and MDA. We used cigarette smoke as a model for NP that we expected to induce 
oxidative stress in the lungs (35). We tested the hypothesis that EBC of healthy non-
smokers exposed to side smoke cigarette would contain increased levels of particles 
and oxidative stress biomarkers compared to their own control measurements before 
exposure. 
 
Materials and methods 
The chosen study design was a repeated exposure of healthy volunteers to three 
different levels of cigarette side smoke in an inhalation chamber with repeated EBC 
collection. 
 
Study participants 
The study was approved by the Ethics Committee of the Faculty of Biology and 
Medicine from the University of Lausanne. Fifteen healthy non-smoker volunteers were 
included. Criteria for participating in the study were: male; non-smoker (or ex-smoker 
for more than 10 years); no chronic or acute respiratory illness; no current use of any 
medication (including vitamins); no diabetic problems; no allergies; BMI smaller than 
30; no coffee, tea or alcohol consumption 24 hours before the first EBC collection. The 
inclusion process consisted of a first visit with a medical examination, the presentation 
of the exposure cabin and instructions on how to use the EBC collection system. After 
the medical staff confirmed that the subject could be included, written informed consent 
was obtained and a second visit was scheduled for the exposure experiment.  
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Study design 
The exposure level (defined by the number of cigarettes to be burned simultaneously) 
was randomly assigned to each study participant before the experiment. The exposure 
chamber (36) (total volume of 10 m³) had a controlled pulsing-aspiration system with an 
air exchange rate of 9.3 h-1 and a HEPA-filter for the incoming air. To exclude potential 
circadian effects on biomarker levels (37), the exposure started for all subjects in the 
morning between 8:30 and 9:30 am.  
After arrival on the day of exposure, information about health status, food consumption 
(coffee,J) and particulate matter exposure during the 24 hours before the experiment 
were obtained from each subject through a questionnaire. After entering the exposure 
chamber, the subject was asked to sit on a chair to provide the first EBC sample 
(named EBC 1, considered as control). The EBC was collected by breathing for 10 
minutes through a pre-cooled (at -20°C) RTube® (Respiratory Research Inc, Austin Tx, 
USA). Next, depending on the planned exposure level, a varying number of cigarettes 
(1 to 3, with one volunteer exposed to 4 cigarettes for each burning cycle) were lit 
inside the cabin near the air entry using a house-made system. The cigarette brand 
used was Marlboro red (tar: 10 mg, nicotine: 0.8 mg, carbon monoxide: 10 mg – Philip 
Morris data). Cigarettes were burned passively. After completion and an additional 
waiting time of 10 minutes, the subject was asked to recharge the lightning system with 
new cigarettes (same number) to start a second cycle of cigarette smoke generation. 
Immediately after the second set of cigarettes finished burning, a second 10 minutes 
EBC collection (EBC 2) was done. After another two burning cycles, a third 10 minutes 
EBC was collected (EBC 3). Depending on the exposure level, each volunteer was 
exposed to the combustion of a total of either 4, 8, 12 or 16 cigarettes. The subject 
stayed two more hours inside the cabin (filtered air) and EBC 4 and EBC 5 were 
collected one and two hours, respectively, after the last particle exposure. The subjects 
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were allowed to read or work with a computer inside the cabin, and to drink non 
sparkling mineral water.  
 
Exposure characterisation  
Active sampling equipment and direct reading instruments were used to characterize 
the exposure inside the cabin. The mass of airborne particulate matter (PM) was 
determined as PM4 (PM smaller than 4 µm, referred to as the "alveolar fraction" in 
occupational health, sampled with using a Casella cyclone head onto 37 mm Teflon 
filter-SKC Inc, Eighty Four USA at a flow of 2 L/min) and as PM2.5 (PM smaller than 2.5 
µm corresponding to the "alveolar fraction" in environmental health, sampled with an  
impactor head-PEM® SKC Inc, Eighty Four USA onto a 37 mm Teflon filter-SKC Inc, 
Eighty Four USA - at a sampling flow of 10 L/min). At the beginning and at the end of 
the sampling, the air flow of the pumps was controlled. All filters were conditioned 
before and after sampling for at least 24 hours at constant humidity (60±10%) and 
ambient temperature before weighting.  
Organic (OC), elemental (EC) and total (TC, the sum of OC plus EC) carbon content of 
the particles collected with the PM4 sampler on plasma treated quartz filters 
(Whatmann QM-A, 37 mm, WWR International, Geneva, Switzerland) was analyzed 
using a coulometric method (38) accredited following the ISO/IEC 17025 norm. As a 
qualitative control for potential interferences of airborne compounds with the H2O2 and 
MDA measurements, air was sampled at 0.5 L/min through an impinger filled with 10 
ml water. This aqueous solution was included in the MDA and H2O2 analyses.   
Direct reading instruments were used to observe the conditions the subjects 
experienced inside the cabin. Temperature and humidity was monitored with an Ecolog 
sensor (Elpro, Buch, Switzerland). PM2.5 was monitored with a personal Data Ram 
(pDR 1000 instrument; Thermo Electron Corporation, Contrec, Dietikon, Switzerland), 
which was zeroed before each use in a HEPA-filtered hood. A Scanning Mobility 
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Particle Sizer (SMPS, Grimm Aerosol Technik, model 5403 with long column, Ainring, 
Germany) was used to monitor the particle size distribution and to calculate the total 
particle surface of the particles in the cabin. It was configured to monitor the particle 
size distributions between 11 and 1083 nm. Finally, a photoelectric aerosol sensor 
(PAS 2000; EcoChem Meβtechnik, Dietikon, Switzerland) was used to assess the time-
course of particle-bound PAH concentration.  
 
Spirometry and EBC collection  
Forced expiratory maneuvers were done before exposure and at the end of the 
experiment (2 hours post-exposure) under the supervision of the same technician using 
a MicroLab spirometer (Micro Medical Ltd, Rochester, UK). Spirometric parameters 
retained were forced expiratory volume in the first second (FEV1), the forced vital 
capacity (FVC), the forced expiratory ratio (FEV1/FVC), and the forced expiratory flow 
(FEF25-75) expressed in percent of the predicted values following the European 
Respiratory Society recommendations (39).  
Before use, the RTube® was thoroughly rinsed with ultrapure water and air dried in a 
clean environment. Volunteers were asked to breathe normally for 10 minutes through 
a mouthpiece while wearing a nose clip. Up to 2 ml of condensate was collected. About 
500 µl was used immediately to determine the particle size-number distribution and the 
total reducing capacity. The rest was aliquoted for H2O2 and MDA analysis. H2O2 was 
analysed the same day and the aliquot for MDA was stored at -78°C and analyzed 
within 1.5 months.  
 
Particle size-number distribution in EBC 
The particle size-number distribution (sphere equivalent hydrodynamic diameter) in 
EBC was determined within 30 minutes after EBC collection by nanoparticle tracking 
analysis (NTA, Nanosight LM20, Nanosight Ltd, Salisbury, UK). About 300 µl of EBC 
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was directly injected in the flow cell of the viewing unit without any further treatment. 
For each sample, 3 to 5 videos of 30 seconds duration were recorded and analyzed 
(NTA software version 2.0).  
The expected dose of cigarette smoke particles deposited in the lungs was estimated 
by entereing the airborne size distribution obtained with the SMPS equipment into the 
Multiple Path Particle Dosimetry model (MPPD software version 2.0, RIVM/CIIT). The 
model used the Yeh/Schum symmetric, and assumed a fractional residual capacity 
volume of 3300 ml, upper respiratory tract volume of 50 ml, breathing frequency of 
12/min, tidal volume of 65 ml, and nasal breathing. The particle size distribution was 
split into logarithmically-spaced particle size bins; each bin was considered 
monodisperse and the MPPD was run separately for each size bin. The obtained head, 
trachea-bronchial and alveolar deposition percentage were then applied to the 
corresponding particle number concentration for each bin and summed up to obtain the 
total deposition.  
 
Measurement of oxidative stress biomarkers in EBC  
H2O2 was measured in EBC based on a chemiluminescent-based procedure described 
by Zappacosta (40) and Navas-Diaz (41).  Briefly, 10 µl of a freshly prepared mixture 
containing luminol 3.3 mM (Sigma-Aldrich, Buchs, Switzerland) with horse radish 
peroxidase 3.3 U/ml (acidic isoenzyme type X, Sigma-Aldrich, Buchs, Switzerland) was 
injected sequentially in a 96 well containing 300 µl EBC or H2O2 standard solution and 
thermostatised at 37°C. The produced luminescence was recorded every 20 second 
during 5 minutes using a Tecan infinite M200 (Tecan, Männedorf, Switzerland). 
Malondialdehyde (MDA), considered as a marker for lipoperoxidation, was analysed 
following the procedure described by Larstäd (22). After MDA derivatisation with 
thiobarbituric acid (Sigma-Aldrich, Buchs, Switzerland) at pH 3.9 and 95°C during 60 
minutes, the reacting mixture was analyzed by injecting 10 µl of the sample in a HPLC 
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system (Varian 9012) equipped with a Nucleosil 100 C18 column (MachereyNagel, 
MSP, Zollikofen, Switzerland) in isocratic mode (0.8 ml/min phosphate buffer 20 mM, 
pH 6.9:acetonitrile 80:20) and a fluorescent detector (excitation 532 nm; emission: 553 
nm, Shimazu). Calibration was done with MDA tatrabutylammonium salt (5-100 nM in 
water, Sigma-Aldrich, Buchs, Switzerland). 
The total reducing capacity was measured using an electrochemical based technique 
(EDELSCAN, Edeltherapeutics SA, Lausanne, Switzerland), as described in Sauvain 
(42). The EBC sample was diluted 2 times in phosphate buffer pH 7.4 0.1M. 
 
Statistical analysis 
Pre-post exposure differences in the respiratory parameters were compared using a 
paired T-test. The oxidative stress biomarkers in EBC were modeled as a linear 
function of the cumulative exposure and two indicators of the post-exposure EBCs in 
the framework of a linear mixed model with random subject-specific intercept. The 
exposure coefficient can thus be interpreted as a mean within-subject increase of the 
biomarker per unit exposure. The parameters of the two indicators can be interpreted 
as the “recovery”, that is decrease in the biomarker concentration, one hour 
(respectively two hours) after the cessation of exposure. 
 
Results 
Demographic and functional characterization of the participants. 
All 15 subjects successfully terminated their participation in the experiments. Their 
demographic and functional characteristics are summarized in Table 1. We did not 
detect any significant changes in the spirometric values from before to post exposure 
(T-test).  The mean collected EBC volume was 1.34±0.22 ml from a minimum of 0.93 
ml to a maximum of 2.05 ml. 
Exposure characterization 
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The exposure levels followed the combustion pattern of the cigarettes (Figure 1).  
The particle mass concentration in the chamber was linearly correlated with the 
number of cigarettes burned, each generating on average about 120 µg/m3 of PM2.5. 
Table 2 presents the average values of the different parameters measured during the 
exposure of the volunteers. The average background number concentration measured 
in the cabin during these experiments was 2’600±1’100 particles/cm3. Smoke 
generation at days with high relative humidity tended to result in lower than expected 
number concentrations and particle surface. The particle size distribution was mainly 
monomodal with an average geometric size of 65 ± 12 nm and a mean geometric 
standard deviation of 1.88 ± 0.06 nm. Considerable variations in the particle size were 
observed when single cigarettes were burned (range from 30 to 82 nm).  
The collected cigarette smoke particles were composed mainly of organic carbon. The 
average OC/TC ratio for all the exposure experiments was 0.89±0.01. The average 
PAH signal obtained from the PAS-device was not linearly correlated to the particle 
mass concentration, but rather to the particle surface (see the supplemental material 
for a detailed analysis of the exposure conditions). All the cumulative exposure 
variables (total number and surface of particles; mass and PAH concentration) were 
strongly correlated to each other (r2 > 0.83). 
 
Estimation of particle number concentration in EBC 
Figure 2A presents the measured particle concentration in the collected EBC, which 
ranged from 0.3E8 to 9.9E8 particles/ml. 50% of the particles observed in EBC 1 
(considered as the control) have a diameter smaller than 161±47 nm, with the 90th 
percentile of the particles being smaller than 320±146 nm. These percentile values are 
not statistically different for the other EBC samples (see supplemental material Figure 
S3).  
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The MPPD model resulted in an average total deposited particle number at the end of 
the exposure of (4.6±1.7)E12; (6.3±0.9)E12 and (7.0±1.9)E12 particles for respectively 
low (total of 4 cigarette burned per volunteers), medium (total of 8 cigarette burned per 
volunteers) and high exposure level (total of ≥ 12 cigarette burned per volunteers). If 
assuming a lung lining fluid volume of 12 ml (43) and no agglomeration of the particles, 
the expected particle concentration in the lung lining fluid would be between 3.8 - 
5.8E11 particle/ml. Neither airborne particle counts nor the modeled deposition numbers 
were correlated with the EBC number concentrations.  
 
Oxidative stress biomarkers in EBC 
Table 3 presents the average concentrations of the different biomarkers before 
exposure (EBC 1). 8% of all the samples were below the limit of detection (LOD) of 
H2O2 (0.1 µM, corresponding to three time the blank variability) and 11% were below 
the LOD for MDA (3.4 nM). The inter-individual variability (ratio of the standard 
deviation divided by the mean value expressed as percentage) of EBC 1 for H2O2, 
MDA and total reducing capacity was 55%, 87% and 13%, respectively. 
Figure 2 shows the concentrations of the different markers in EBC during the course of 
the experiment. For the statistical analysis, the experiment was divided into two 
phases: Phase I corresponded to the exposure status lasting about 1 hour (EBC 2 and 
3); and Phase II corresponded to the post-exposure situation (EBC 4 and 5). Both, 
MDA and H2O2 increased significantly (Table 4) with the total cumulative number of 
particles (consider to be a proxy of all other exposure variables) during the exposure. 
The general pattern consisted of an increase of these two biomarkers in EBC during 
the exposure time (phase I), followed by a decrease one hour after cessation of the 
exposure (phase II). This decrease was not statistically significant for MDA but was 
clearly significant for H2O2 (p=0.001, Table 4). In addition, an increasing H2O2 
concentration was observed again after 2 hours post-exposure. Two hours post 
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exposure, the MDA and H2O2 levels in EBC were statistically different from the control 
(EBC 1, Table 4). The total particle number concentration and the total reducing 
capacity did not change by the exposure. However, a tendency to increase was 
observed for the total reducing capacity levels in the two post-exposure EBC (Table 4). 
 
Discussion 
This study investigated the deposition of ultrafine particles in the lungs and the 
resulting oxidative stress at the example of tobacco smoke. While nanoscaled particles 
were detected in EBC, it was not possible to relate their concentration to the exposure 
levels. Both, H2O2 and MDA concentrations in EBC were significantly increased during 
exposure to cigarette smoke. H2O2 levels showed a bi-phasic pattern with an increase 
during exposure, a significant decrease in the first hour after exposure, and a second 
increase 2 hours post-exposure. In contrast, MDA did not decrease during the post-
exposure time with all subjects having very similar MDA-levels at the past EBC value, 
as indicated by the small interquartile range (Figure 2C). Neither the total reducing 
capacity in the EBC nor any of the spirometric parameters were significantly associated 
to any of the exposure parameters.   
The particles were composed mostly of organic compounds with a size range in the 
sub-micrometer and nanoscale. Cigarette smoke is a complex mixture of different 
pollutants as it contains large amounts of gas and particle phase radicals (44) and other 
oxidants capable of inducing oxidative stress (35). The PM2.5 levels used in this study 
corresponded to levels than can be observed in restaurants and bars in Switzerland (45). 
The aerosol characteristics in our study were not identical when a different number of 
cigarette were burned (Table 1 and supplemental material). The differences are not 
extreme and systematic; for example a geometric mean size of 58 nm for one cigarette 
compared to 64-77 nm for multiple cigarettes or the ratio of PAH/mass decreasing from 
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0.73 for one cigarette to 0.51 for ≥ 3 cigarettes. Thus, it is unlikely that these 
differences prevented the detection of effects in the statistical analysis. 
 
Evaluation of deposited particles 
To our knowledge, this is the first study to investigate the particle concentration in EBC 
in connection with NTA. Large amounts of particles were detected in EBC with this 
technique. However, the total number of particles in EBC was not significantly changed 
by the tobacco smoke exposure. The MPPD deposition model suggests that the 
resulting particle dose after exposure correspond to about 3.8 - 5.8E11 particle/ml in the 
lung lining liquid. The measured particle concentrations in EBC were by a factor of 
thousand smaller. This corresponds to the lower dilution factor reported for lung lining 
fluid in EBC (46). Thus one would have expected to see an increase of particles 
following exposure. The pre-exposure analysis shows that the condensed liquid 
contains already a considerable number of small particles, possibly some originating 
from the body such as cell debris, large proteins, and also ambient air pollution 
particles. Tobacco particles are relatively small and composed of a combination of solid 
and soluble organic compounds. These latter can quickly dissolve in the lung lining 
fluid, thus diminishing the number of particles that are sufficiently large to be detected 
with the NTA instrument. The smallest carbonaceous particle size which can reliably be 
detected with this technique is around 60 nm (47), which may be the key limiting factor. 
The size-number distribution determined with the NTA technique uses light diffusion, 
which is a generic property of particles. Without measuring a specific physical property 
of the cigarette smoke particle, the unambiguous determination of the deposited dose 
cannot be done with the described protocol. This uncertainty could be solved in 
laboratory settings by using non-toxic fluorescent nanoparticles and tracking their 
Brownian motion with a specific excitation and emission wavelength, or by using 
methods that include the chemical analysis of particles. In the case of metallic particles 
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for example, the use of single-particle inductively coupled plasma mass spectrometry 
(sp-ICP-MS) could be an interesting technique (48). An additional phenomena that could 
have prevented the detection of smoke particles is the particle growth in the airways (49) 
followed by their internalization into vesicles or micelles. It was suggested that exhaled 
lining fluid aerosols have the form of vesicles (50) and NTA does detect such structures 
(51). Thus, the agglomerated smoke particles could be internalized in these vesicles and 
could not be detected by NTA as a consequence of insufficient high numbers but 
because they were no longer individual particles. 
 
Oxidative stress biomarkers in EBC  
We had the hypothesis that inhaled particles will induce an oxidative stress in the lung 
lining fluid upon inhalation. H2O2 and MDA increased in EBC during the phase I. This is 
concordant with already published data showing an early increase of H2O2 levels 30 
minutes after cigarette smoke exposure (37, 52). This could indicate that our hypothesis is 
correct. However, alternative explanations need to be assessed as well. When passing 
the air during the exposure phase through an impinger filled with water, we detected 
compounds present in the gaseous phase that could be interpreted as H2O2 or MDA. 
Cigarette smoke contains large amount of H2O2 in it gaseous phase 
(53) and 
associations between H2O2 levels in ambient air and H2O2 levels in EBC were reported 
(54). However, it remains unclear whether the H2O2 increase in EBC 2 and 3 (collected 
during exposure) is related solely to gaseous H2O2 or if some was transported by or 
generated on the particles' surface (55). Cigarette smoke is chemotactic to neutrophils 
and macrophages and can activate them (35). However, the activation of immune cells 
usually takes several hours. Thus, the initial burst in H2O2 is most likely not related to 
immune cells, whereas such a mechanism could well explain the delayed increase of 
H2O2 during phase II (EBC 5). This increase could also result from the direct production 
of reactive oxygen species by the deposited cigarette smoke particles or could be the 
 17 
sign of a transient inflammatory process in the lungs produced by airway epithelia (56) or 
alveolar macrophages and type-II pneumocytes (54). Normalisation of H2O2 levels after 
the cessation of cigarette smoke exposure has been reported to last 10-12 hours for 
children exposed to passive smoke (57) or for smokers having stopped smoking for at 
least 10h (52). In addition to the changes related to the exposure, H2O2 in EBC seem to 
show a circadian pattern (37). However, it would not interfere with the dose-effect 
evaluation because we controlled for such patterns by standardizing the time of 
exposure and health effect assessment.  
Acrolein is an important carbonyl emitted by cigarettes (58) and is known to react with 
thiobarbituric acid, the derivating agent used for the MDA measurement (59). To confirm 
that acrolein can interfere in the MDA detection, we proceed a pure water-based 
acrolein standard with the analytical method for MDA and indeed observed a dose 
dependent signal (see suppelementary material, Figure S4). This suggests that 
acrolein interfered with the MDA measurement. The acrolein concentration in tobacco 
smoke would be sufficiently large to explain most of the elevated MDA values in EBC 3 
(supplemental material, Table S1). MDA was proposed to be a product from lipid 
peroxidation that occurs during oxidative damage to cell membranes and it is unclear if 
lipoperoxidation would be sufficiently rapid to increase MDA in the time frame of phase 
I. Additional studies are needed to clarify if some of the signal still could be related to 
lipoperoxidation.  
We observed a statistically significant MDA increase between EBC 1 and EBC 5 
(collected 2 hours post-exposure Fig 4C), but, contrary to H2O2, no post-exposure 
decrease could be observed until the last EBC-sample. MDA is a small molecule and it 
should start to disappear if it was only an exposure marker for acrolein. However, if the 
lipoperoxide degradation process was slow, it is possible that the EBC 2 and 3 mostly 
reflected exposure to acrolein, while after 2 hours, the MDA production resulting from 
the lipoperoxidation was the predominant source (30). The mixed effect model only 
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confirms that the MDA signal is correlated to exposure.  However, the above suggested 
timing would be in agreement with another study that investigated ambient air particles 
(up to 250'000 PM1 particles/cm
3 during moderate exercise) and found an increase in 
MDA levels in EBC 30 minutes post-exposure compared to pre-exposure (60).  
We did not observe any change in the total reducing capacity in the collected EBC and 
also the mixed model did not find any association with exposure. This suggests that the 
healthy volunteers maintained the redox balance at the organ level even though local 
oxidative damage did occur, as suggested by the MDA findings.  However, we cannot 
exclude that the exposure may have triggered the production of antioxidants because 
for that to occur, activation of antioxidant-related genes is required (61). In human 
monocyte cell lines and primary blood mononuclear cells stimulated with cigarette 
smoke extract, a 1.5 fold upregulation of genes related to antioxidants was observed 8 
hours post-exposure (62). 
In summary, we found that EBC contains large numbers of sub-micron particles but 
these could not be related to the level of cigarette smoke the volunteers were exposed 
to. On the contrary, H2O2 and MDA concentration in EBC showed significant changes 
in the hours following exposure to cigarette smoke. This seems to represent initially the 
deposition of particles and gases in the lung lining liquid, and later the start of oxidative 
stress with associated cell membrane damage. Future studies should extend the 
follow-up time and should remove gases or particles from the air to allow differentiating 
between the different sources of H2O2 and MDA. This would also help to determine in 
which conditions both compounds could be considered as biomarkers of exposure or 
effect. In addition, it would be worth measuring other biomarkers of exposure/effect in 
EBC, including for example 8-isoprostane (63, 64) and small molecular weight metabolites 
by NMR spectroscopy (65, 66). The use of breath analysis by electronic noses could also 
help the monitoring of lung damage (67,68), as it has been reported to be a reproducible 
technique ( 69). 
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Tables 
 
 
Table 1: Characteristics of volunteers and their lung parameters. 
 All 
Pre-exposure 
All 
Post-exposure 
p-value 
Age 26.3 ± 6.5 (15) - - 
BMI 23.1 ± 2.6 (13) - - 
FEV1 (L) 4.4 ± 0.4 (12) 4.4 ± 0.5 (13) 0.97 
FEV1 (% pred) 100.3 ± 8.4 (12) 100.1 ± 9.7 (13) 0.97 
FVC (L) 5.0 ± 0.5 (12) 5.0 ± 0.8 (13) 0.97 
FVC (% pred) 97.4 ± 8.6 (12) 96.2 ± 11.0 (13) 0.76 
FEV1/FVC  87.0 ± 5.0 (12) 87.7 ± 5.7 (13) 0.75 
FEF25-75 (L) 4.9 ± 1.0 (12) 4.9 ± 1.0 (13) 0.96 
FEF25-75 (% pred) 96.9 ± 21.1 (12) 98.1 ± 19.7 (13) 0.88 
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Table 2: Average exposure conditions (± standard deviation) during the 15 
experiments, grouped in function of the number of cigarettes burned.  
 Low (n=5) Medium (n=5) High (n=5) 
# cigarettes  4 x 1 4 x 2 4 x ≥ 3 
T [°C] a 
 
22.2 ± 0.12 23.6 ± 0.12 22.7 ± 0.43 
Humidity [% rH] a 29.9 ± 1.4 35.5 ± 1.0 27.9 ± 3.3 
PM2.5 (PDR) [µg/m
3] 117 ± 4 240 ± 25 370 ± 18 
OC [µg/m3]a 71 ± 2 119 ± 4 170 ± 8 
EC [µg/m3]a 10 ± 1 15 ± 1 18 ± 2 
PAH (PAS) [ng/m3] 85 ± 2 162 ± 2 188 ± 9 
Total # [/cm3] 225’000 ± 15’200 307’500 ± 13’400 428’600 ± 29’400 
Geom size [nm] 58 ± 3 64 ± 1 77 ± 2 
Total surface [mm2/m3] 4’920 ± 203 8’270 ± 340 15’500 ± 640 
a : corresponds to the average over all the time the volunteer stayed in the cabin 
(exposure + post-exposure). 
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Table 3: Average concentration of biomarkers in the control EBC (EBC 1). 
Variable Mean Std deviation Min Max 
MDA [nM] 5.6 4.9 < LOD (3.4 nM) 21.6 
H2O2 [µM] 0.21 0.14 < LOD (0.1 µM) 0.43 
Total reducing capacity [a.u.] 52 7 43 67 
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Table 4:  Mixed models – Phase I and II based on the cumulative total number of 
particles in the air as the exposure variable.  
 Exposure 
(cumulative total number) 
1 hour post 
exposure 
2 hours post 
exposure 
Constant 
Model for particle number in EBC 
Coefficient (0.19±2.3)E-8 -0.01±0.66 0.31±0.72 3.17±0.44 
p 0.935 0.985 0.662 0.001 
Model for Log MDA 
Coefficient (2.0±0.6)E-8 -0.22±0.17 -0.13±0.17 1.67±0.14 
p 0.001 0.185 0.473 0.001 
Model for Log H2O2 
Coefficient (5.2±1.3)E-9 -0.17±0.03 -0.03±0.04 0.26±0.03 
p 0.001 0.001 0.394 0.001 
Model for Log Total reducing capacity* 
Coefficient (0.98±1.32)E-9 0.02±0.03 0.06±0.04 3.94±0.04 
p 0.457 0.474 0.129 0.001 
*: without one outlier. 
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Figure legends 
Figure 1: Typical exposure levels (number concentration: left axis; PAH concentration and 
PM2.5 concentration: right axis) encountered for an experiment where 1 cigarette was burned 
4 times. The collection of the five EBC samples (10 minute duration) is indicated with the 
grey bars. Abbreviations: SMPS: Scanning Mobility Particle Sizer; PAS: Photoelectric 
Aerosol Sensor; pDR: Personal DataRam. 
 
Figure 2: Variation of the different markers measured in EBC in function of the sampling 
(EBC N° 1 corresponding to the before exposure situation – control; EBC N° 2-3 
corresponding to EBC collected during exposure; EBC N° 4-5 corresponding to post-
exposure samples). Panel A: Particle number concentration; Panel B: H2O2 concentration; 
Panel C: MDA concentration; Panel D: Total reducing capacity.  
*: difference with EBC 1 statistically significant (p<0.05, multiplicity corrected p-values). 
¶: difference with EBC 2 statistically significant (p<0.05, multiplicity corrected p-values). 
†: difference with EBC 3 statistically significant (p<0.05, multiplicity corrected p-values). 
ǂ: difference with EBC 4 statistically significant (p<0.05, multiplicity corrected p-values). 
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Supplemental material 
Exhaled breath condensate as a matrix for combustion-based 
nanoparticle exposure and health effect evaluation.  
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1 Institute for Work and Health, Route de la Corniche 2, CH-1066 Epalinges - 
Lausanne (Switzerland). 
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Size distribution of the different exposure experiments  
Figure S1 presents the averaged size distribution of the cigarette smoke particles 
measured during the exposure of the different volunteers. Each size distribution 
corresponds to the average of the four ignition of a different number of cigarette (low=1 
cigarette/ignition; medium=2 cigarettes/ignition; high=3 cigarettes/ignition, with one 
volunteer exposed to 4 cigarettes/ignition – Test N° T2). Measurements have been 
done with a SMPS (Grimm Aerosol Technik, model 5403 with long column, Ainring, 
Germany).  
The exposure conditions for the test N° T10 were different from the other (Figure S1, A: 
Low exposure) and corresponded to a rather high generation of small particles. 
Whereas temperature and relative humidity during this generation were around the 
average value, this difference could be due to the fact that all the cigarettes were not 
conditioned in a controlled environment, possibly generating variability in the burning 
conditions. 
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Figure S1: Average size distribution of the cigarette smoke during the different 
generations. Each test ID are given on the upper right part of each graph  
A: Low exposure 
 
B: Medium exposure 
 
C: High exposure 
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Figure S2: Association between the different variables measured by direct reading 
instruments during each cigarette burning. Numbering corresponds to the different 
tests done.  
  
  
 
 
 
 
 
 
A B 
C 
E 
D 
 4
Figure S2 presents the association between the different exposure variables recorded 
by direct reading instruments. Each point corresponds to the averaged concentration 
measured during each cigarette burning (4 point for each test). The label of each point 
corresponds to the test ID. A statistically significant non-linear relationship is observed 
for the particle surface and PAH content in function of the mass (p<0.011 for a square 
term in the regression model, see panel B and C respectively), suggestive of an 
agglomeration process in the air at high particle concentrations. On the contrary, when 
the SMPS-based surface is considered, a linear relationship (p<0.001) is observed with 
the particulate PAH concentration (Panel E). This linear relationship is expected based 
on the measurement principle of the PAS instrument (1). As the surface variable is 
calculated based on the particle number measured with the SMPS, it is not surprising 
that a similar linear relationship is observed between the PAS signal and the particle 
number in the air (Panel D). 
 
Size distribution of the particles in EBC 
Figure S3 illustrates the different averaged size distribution in EBC. In Figure S3, the 
size distribution at 00:00 min corresponds to EBC 1 (control); the second and third 
curves correspond to EBC 2 and 3 (just after exposure episodes) whereas the fourth 
and fifth curves correspond to EBC 4 and 5 (about 1 and 2 hours post exposure). 
The averaged coefficient of variation (CV) on the particle concentration (corresponding 
to the ratio of the standard deviation for each size range divided by the averaged 
particle concentration, expressed in percent) for all these size distribution was 117%. 
This rather high CV could be due to the variability observed between the different 
smoke generations and with an additional contribution from the inter-individual 
variability.  
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Figure S3: Averaged (n=5) size distribution of particles in EBC for volunteers exposed 
to low (panel A), medium (panel B) or high (panel C) levels of cigarette smoke.  
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Measurement of acrolein with the MDA methodology 
We prepared different standard solution of acrolein (>99%, for electron microscopy, 
Fluka) by dilution of a mother solution of 8.9 mM with water. The studied concentration 
was comprised between 8.9 and 225 µM. These solutions were derivatised with TBAR 
in the same manner as for MDA. The resulting peak at the same retention time as for 
the MDA was quantified with a calibration curve obtained with tetrabutyl-ammonium 
MDA. Figure S4 presents the resulting relationship between the acrolein concentration 
in the standard solutions and the equivalent MDA concentration produced when 
applying the analytical protocol.  
 
Figure S4: Relationship between the acrolein concentration in the standard and the 
measured MDA equivalent when applying the analytical procedure described under 
Materials and Methods for MDA. Error bars correspond to the standard deviation of 3 
independent measurements. 
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Table S1 presents the calculation done to estimate the contribution of the acrolein to 
the MDA concentration in EBC. This calculation indicates that the MDA increase 
between EBC 1 (control) and EBC 3 (just after the exposure) could be largely 
attributable to the inhalation of acrolein generated by the combustion of the cigarettes.  
 
 Table S1: Estimated contribution of acrolein from the cigarette combustion to the MDA 
level measured in EBC.  
Acrolein level per cigarette [µg/cig]    Reference 
Best case [µg/cigarette] 63   
2 
Worst case [µg/cigarette] 167   
2 
Concentration of acrolein during exposure     
Number of cig burned in the 10 m3 cabin 4 8 12  
Acrolein concentration in air; best case [µg/m3]  25 50 76  
Acrolein concentration in air; worst case [µg/m3]  67 133 200  
Mass of inhaled acrolein during cigarette exposure     
Volume inhalted/min [L/min] 6    
Exposure duration [min] 60    
Total deposition in the lower respiratory tract [%] 98   3 
Mass acrol inhaled; best case [µg] 8'891 17'781 26'672  
Mass acrol inhaled; worst case [µg] 23'496 46'993 70'489  
Concentration of acrolein in EBC     
Volume of lung lining fluid [ml] 12   
4 
Dilution factor 10'000   
5 
Concentration of acrolein in EBC; best case [µg/ml] 0.07 0.15 0.22  
Concentration of acrolein in EBC; worst case [µg/ml] 0.20 0.39 0.59  
Concentration of acrolein in EBC; best case [nmol/ml] 1.32 2.65 3.97  
Concentration of acrolein in EBC; worst case [nmol/ml] 3.50 6.99 10.49  
Acrolein contribution to the MDA measurement     
Calibration curve: MDA = 0.4133*Acrol1.31    This work 
Concentration MDA attributable to acrolein; best case [nM] 0.6 1.5 2.5  
Concentration MDA attributable to acrolein; worst case [nM] 2.1 5.3 9.0  
Average MDA concentration measured; control [nM] 5.6    
Average MDA concentration measured in EBC 3 [nM] 6.6 8.1 18.8  
Average measured MDA increase [nM] 1.0 2.5 13.2  
Acrolein contribution; best case [%] 61 60 19  
Acrolein contribution; worst case [%] 218 214 68  
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